Occurrence of dyslipidemia in spontaneous intracerebral hemorrhageHERZIG, Roman; VLACHOVA, Ivanka; MARES, Jan et al.European journal of lipid science and technology (Print). 2006, Vol 108, Num 5, pp 383-388, issn 1438-7697, 6 p.Article

Observational Study of Hypertension in Matelica, Italy (Matelica Hypertension Study)SOSSAI, P; AMENTA, F; PORCELLATI, C et al.Clinical and experimental hypertension (1993). 2007, Vol 29, Num 8, pp 531-537, issn 1064-1963, 7 p.Article

Association of risk factors with increased pulse wave velocity detected by a novel method using dual-channel photoplethysmographyTSAI, Wei-Chuan; CHEN, Ju-Yi; WANG, Ming-Chen et al.American journal of hypertension. 2005, Vol 18, Num 8, pp 1118-1122, issn 0895-7061, 5 p.Article

Managing metabolic complications of peritoneal dialysisPENNELL, P; ROJAS, C; ASIF, A et al.Clinical nephrology. 2004, Vol 62, Num 1, pp 35-43, issn 0301-0430, 9 p.Article

Dyslipidemia in PCOSWILD, Robert A.Steroids. 2012, Vol 77, Num 4, pp 295-299, issn 0039-128X, 5 p.Conference Paper

Influence of rutin treatment on biochemical alterations in experimental diabetes : DIABETESHENRIQUE FERNANDES, Ana Angélica; BARBOSA NOVELLI, Ethel Lourenzi; OKOSHI, Katashi et al.Biomedicine & pharmacotherapy. 2010, Vol 64, Num 3, pp 214-219, issn 0753-3322, 6 p.Article

FABP4 predicts atherogenic dyslipidemia development. The PREDIMED studyCABRE, Anna; BABIO, Nancy; LAZARO, Iolanda et al.Atherosclerosis. 2012, Vol 222, Num 1, pp 229-234, issn 0021-9150, 6 p.Article

Increased arterial stiffness in familial combined hyperlipidemiaBROUWERS, Martijn C. G. J; REESINK, Koen D; VAN GREEVENBROEK, Marleen M. J et al.Journal of hypertension. 2009, Vol 27, Num 5, pp 1009-1016, issn 0263-6352, 8 p.Article

Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapyARNEDO, Mireia; TAFFE, Patrick; BERGMANN, Sven et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 9, pp 755-764, issn 1744-6872, 10 p.Article

Complementary and alternative therapies for the management of dyslipidemiaNIES, Leslie K; CYMBALA, Alicia A; KASTEN, Sheila L et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 11, pp 1984-1992, issn 1060-0280, 9 p.Article

Dyslipidemia and insulin resistance in relation to genetic admixture among Hispanics and non-Hispanic blacks of Caribbean originTULL, Eugene S; THURLAND, Ann.Journal of the National Medical Association. 2004, Vol 96, Num 3, pp 332-340, issn 0027-9684, 9 p.Article

Dyslipidemia Control in Indigent Patients Receiving Medication Assistance Compared with Insured PatientsMARRS, Joel C; SASEEN, Joseph J.Pharmacotherapy. 2008, Vol 28, Num 5, pp 562-569, issn 0277-0008, 8 p.Article

Prediction of genetic risk for dyslipidemiaYAMADA, Yoshiji; MATSUO, Hitoshi; ICHIHARA, Sahoko et al.Genomics (San Diego, Calif.). 2007, Vol 90, Num 5, pp 551-558, issn 0888-7543, 8 p.Article

A Randomized, Double-Blind Study of Fenofibric Acid Plus Rosuvastatin Compared With Rosuvastatin Alone in Stage 3 Chronic Kidney DiseaseWEINSTEIN, Debra L; WILLIAMS, Laura A; CARLSON, Dawn M et al.Clinical therapeutics. 2013, Vol 35, Num 8, pp 1186-1198, issn 0149-2918, 13 p.Article

Pharmacokinetics of Rosuvastatin/Olmesartan Fixed-Dose Combination: A Single-Dose, Randomized, Open-Label, 2-Period Crossover Study in Healthy Korean SubjectsSON, Hankil; ROH, Hyerang; LEE, Donghwan et al.Clinical therapeutics. 2013, Vol 35, Num 7, pp 915-922, issn 0149-2918, 8 p.Article

The Promise of Cholesteryl Ester Transfer Protein (CETP) Inhibition in the Treatment of Cardiovascular Disease : Current and Future Options for Lipid-lowering Therapy Beyond StatinsBOCHEM, A. E; KUIVENHOVEN, J. A; STROES, E. S. G et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 17, pp 3143-3149, issn 1381-6128, 7 p.Article

The Role of Fibrate Treatment in Dyslipidemia: An Overview : Current and Future Options for Lipid-lowering Therapy Beyond StatinsKATSIKI, Niki; NIKOLIC, Dragana; MONTALTO, Giuseppe et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 17, pp 3124-3131, issn 1381-6128, 8 p.Article

A Randomized, Double-blind, Placebo-controlled Trial to Evaluate Efficacy and Tolerability of an Optimized Botanical Combination in the Management of Patients with Primary Hypercholesterolemia and Mixed DyslipidemiaGUPTA, H; PAWAR, D; RIVA, A et al.PTR. Phytotherapy research. 2012, Vol 26, Num 2, pp 265-272, issn 0951-418X, 8 p.Article

Improvement in the High-Fat Diet-Induced Dyslipidemia and Adiponectin Levels by Fish Oil Feeding Combined with Food Restriction in Obese KKAy MiceWAKUTSU, Masaki; TSUNODA, Nobuyo; MOCHI, Yasuki et al.Bioscience, biotechnology, and biochemistry. 2012, Vol 76, Num 5, pp 1011-1014, issn 0916-8451, 4 p.Article

Metabolic syndrome and endometrial cancer riskROSATO, V; ZUCCHETTO, A; BOSETTI, C et al.Annals of oncology. 2011, Vol 22, Num 4, pp 884-889, issn 0923-7534, 6 p.Article

Combined therapy in the treatment of dyslipidemia : Combinaison therapy in cardiovascular diseaseREINER, Zeljko.Fundamental & clinical pharmacology. 2010, Vol 24, Num 1, pp 19-28, issn 0767-3981, 10 p.Article

Evaluation of a Pharmacist-Managed Telephone Lipid Clinic at a Veterans Affairs Medical CenterFABBIO, Kristin L; BRADLEY, Matthew; CHRYMKO, Margaret et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 1, pp 50-56, issn 1060-0280, 7 p.Article

Dyslipidemia in children with chronic kidney diseaseSALAND, Jeffrey M; PIERCE, Christopher B; MITSNEFES, Mark M et al.Kidney international. 2010, Vol 78, Num 11, pp 1154-1163, issn 0085-2538, 10 p.Article

Sleep pattern in an experimental model of chronic kidney diseaseHIROTSU, Camila; TUFIK, Sergio; TOLEDO BERGAMASCHI, Cassia et al.American journal of physiology. Renal physiology. 2010, Vol 68, Num 6, issn 1931-857X, F1379-F1388Article

Applying the Evidence : Do Patients With Stroke, Coronary Artery Disease, or Both Achieve Similar Treatment Goals?SAPOSNIK, Gustavo; GOODMAN, Shaun G; LEITER, Lawrence A et al.Stroke (1970). 2009, Vol 40, Num 4, pp 1417-1424, issn 0039-2499, 8 p.Article